Abbott Laboratories Valuation
| ABL Stock | EUR 107.52 2.82 2.56% |
At this time, the firm appears to be fairly valued. Abbott Laboratories shows a prevailing Real Value of €108.09 per share. The current price of the firm is €107.52. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as price to sales of 4.35 X, and Current Valuation of 190.22 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Abbott Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Abbott Laboratories is based on 3 months time horizon. Increasing Abbott Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Abbott stock is determined by what a typical buyer is willing to pay for full or partial control of Abbott Laboratories. Since Abbott Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abbott Stock. However, Abbott Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 107.52 | Real 108.09 | Hype 107.52 |
The intrinsic value of Abbott Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abbott Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abbott Laboratories helps investors to forecast how Abbott stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abbott Laboratories more accurately as focusing exclusively on Abbott Laboratories' fundamentals will not take into account other important factors: Abbott Laboratories Total Value Analysis
Abbott Laboratories is presently expected to have takeover price of 190.22 B with market capitalization of 210.39 B, debt of 14.52 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abbott Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
190.22 B | 210.39 B | 14.52 B |
Abbott Laboratories Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Abbott suggests not a very effective usage of assets in January.Abbott Laboratories Profitability Analysis
The company reported the revenue of 43.65 B. Net Income was 6.93 B with profit before overhead, payroll, taxes, and interest of 0.About Abbott Laboratories Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Abbott Laboratories. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Abbott Laboratories based exclusively on its fundamental and basic technical indicators. By analyzing Abbott Laboratories's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Abbott Laboratories's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abbott Laboratories. We calculate exposure to Abbott Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abbott Laboratories's related companies.8 Steps to conduct Abbott Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abbott Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abbott Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abbott Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abbott Laboratories' revenue streams: Identify Abbott Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abbott Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abbott Laboratories' growth potential: Evaluate Abbott Laboratories' management, business model, and growth potential.
- Determine Abbott Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abbott Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Abbott Stock, please use our How to Invest in Abbott Laboratories guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.